ROHTO PHARMACEUTICAL CO.,LTD. [4527.T]
TOKYO, Apr 30 (Pulse News Wire) – Rohto Pharmaceutical CO.,LTD. (4527.T) received two shareholder proposals ahead of its upcoming annual general meeting scheduled for June 24, 2026.
The first proposal was submitted by AVI JAPAN OPPORTUNITY TRUST PLC on April 17, 2026, requesting the removal of one director. The second proposal came from LONGCHAMP SICAV on April 20, 2026, and includes seven items for consideration: establishing a strategic review committee, revising the articles of association concerning dividend distribution decisions, share repurchase plans, approving compensation for restricted stock awards, modifying the composition of outside directors, implementing measures to enhance management focused on capital costs and stock prices, and amending the record date for the annual general meeting.
The board of directors will carefully examine and deliberate on these proposals and will promptly disclose their opinions upon reaching a decision.
🟢 Confidence: High AI-translated content.